SB INVESTMENT ADVISERS (UK) LTD
SB INVESTMENT ADVISERS (UK) LTD's SB INVESTMENT ADVISERS (UK) LTD holds 10 U.S.-equity positions worth $7.7B (SEC 13F, Q1 2026). Top positions: Coupang, Inc. 70.7%, Grab Holdings Limited Class A Ordinary Shares 19.0%, Relay Therapeutics, Inc. Common Stock 3.6%.
Holdings
| Stock | % of portfolio | Shares | Value | Latest activity | Avg buy price | Current price | Date |
|---|---|---|---|---|---|---|---|
| CPNG Coupang, Inc. | 70.7% | 289.5M | $5.5B | — | $16.00 | $17.31 (+8%) | 2026-03-31 |
| GRAB Grab Holdings Limited Class A Ordinary Shares | 19.0% | 401.8M | $1.5B | — | $3.01 | $3.49 (+16%) | 2026-03-31 |
| RLAY Relay Therapeutics, Inc. Common Stock | 3.6% | 27.9M | $278M | — | $16.47 | $17.28 (+5%) | 2026-03-31 |
| COMP Compass, Inc. | 2.1% | 22.0M | $161M | ▼ 12% (−3.1M) | $3.23 | $9.78 (+203%) | 2026-03-31 |
| VIR Vir Biotechnology, Inc. Common Stock | 1.3% | 10.9M | $98M | ▼ 17% (−2.2M) | $23.27 | $9.57 (−59%) | 2026-03-31 |
| AUR Aurora Innovation, Inc. Class A Common Stock | 1.1% | 19.8M | $82M | — | $1.39 | $6.56 (+372%) | 2026-03-31 |
| ROIV Roivant Sciences Ltd. Common Shares | 1.0% | 2.7M | $74M | ▼ 84% (−13.7M) | $7.38 | $31.25 (+323%) | 2026-03-31 |
| NRGV Energy Vault Holdings, Inc. | 0.7% | 15.5M | $51M | ▼ 16% (−3.0M) | $2.14 | $4.42 (+107%) | 2026-03-31 |
| YMM Full Truck Alliance Co Ltd | 0.6% | 5.3M | $44M | — | $7.61 | $7.89 (+4%) | 2026-03-31 |
| DNA Ginkgo Bioworks Holdings, Inc. | 0.1% | 611K | $4M | — | $8.15 | $9.04 (+11%) | 2026-03-31 |
FAQ ▾
What are SB INVESTMENT ADVISERS (UK) LTD's largest holdings?
As of the latest 13F: Coupang, Inc. 70.7%, Grab Holdings Limited Class A Ordinary Shares 19.0%, Relay Therapeutics, Inc. Common Stock 3.6%, Compass, Inc. 2.1%, Vir Biotechnology, Inc. Common Stock 1.3%.
How big is SB INVESTMENT ADVISERS (UK) LTD's 13F portfolio?
$7.7B across 10 disclosed U.S.-equity positions.
Where does this data come from?
U.S. SEC Form 13F-HR institutional holdings filings.
Sourced from SEC Form 13F-HR filings · Not investment advice ▾
Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.